TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presentado dom, 30 ago · 16:45 CESTHot Line 8Todos los ensayos Hot Line →

NEXAF

2026

The Norwegian Exercise in Atrial Fibrillation Trial

In 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.

Resultado

co-primary: (1) total time in atrial fibrillation (burden, %) measured by insertable cardiac monitor over 12 months; (2) AFEQT overall score at 12 months
Diferencia absoluta
3,2 puntos
NNT
32
Estimación del efecto

relative reduction45P = 0,016

La diferencia absoluta y el NNT se derivan de las tasas de eventos.

También se informa: But the co-primary quality-of-life score did not differ (AFEQT +5.6 vs +4.4; P = 0.43). Fitness rose and resting heart rate fell; total hospitalisations were 37% lower and AF-related hospitalisations 46% lower.

Publicación original
Subtema
Exercise
Diseño
multicentre (Trondheim, Bærum/Drammen, Tromsø), open-label, two-arm RCT; 1:1 supervised plus eHealth-based exercise vs usual care; blinded statistical analysis; 12-month follow-up with insertable cardiac monitor
Relevancia
Importante: uno de varios pilares.
Fuente
Nes BM, et al. Presented at ESC Congress 2026, Hot Line 8, 30 August.

Discusión y crítica

Exercise halves the time spent in atrial fibrillation, measured by an implanted monitor rather than by symptoms, the cleanest evidence yet that the arrhythmia itself responds to training. The second co-primary endpoint did not move: patients did not feel better, the same dissociation between rhythm and symptoms that the sham-controlled ablation trial in this session found. Open-label against usual care, 295 patients, and the hospitalisation figures are secondary and unadjusted for multiplicity.